Morgan Stanley Axonics, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Axonics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 287,128 shares of AXNX stock, worth $20.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

287,128

Previous 222,831 28.85%

Holding current value

$20.4 Million

Previous $15 Million 33.54%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$67.3 - $69.67 $4.33 Million - $4.48 Million	64,297 Added 28.85%	287,128 $20 Million
Q2 2024 Oct 17, 2024	SELL	$66.47 - $69.65 $6.17 Million - $6.46 Million	-92,758 Reduced 29.39%	222,831 $15 Million
Q2 2024 Aug 14, 2024	SELL	$66.47 - $69.65 $6.17 Million - $6.46 Million	-92,758 Reduced 29.39%	222,831 $15 Million
Q1 2024 Oct 17, 2024	BUY	$56.67 - $69.36 $5.26 Million - $6.43 Million	92,758 Added 41.63%	315,589 $21.8 Million
Q1 2024 Aug 16, 2024	BUY	$56.67 - $69.36 $1.62 Million - $1.98 Million	28,614 Added 9.97%	315,589 $21.8 Million
Q1 2024 May 15, 2024	BUY	$56.67 - $69.36 $1.62 Million - $1.98 Million	28,614 Added 9.97%	315,589 $21.8 Million
Q4 2023 Aug 16, 2024	BUY	$49.38 - $63.75 $3.17 Million - $4.09 Million	64,144 Added 28.79%	286,975 $17.9 Million
Q4 2023 Feb 13, 2024	BUY	$49.38 - $63.75 $3.67 Million - $4.74 Million	74,320 Added 34.95%	286,975 $17.9 Million
Q3 2023 Nov 15, 2023	SELL	$48.64 - $62.51 $6.87 Million - $8.83 Million	-141,207 Reduced 39.9%	212,655 $11.9 Million
Q2 2023 Aug 14, 2023	SELL	$47.99 - $60.21 $6.95 Million - $8.72 Million	-144,809 Reduced 29.04%	353,862 $17.9 Million
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $7.5 Million - $9.61 Million	142,648 Added 40.07%	498,671 $27.2 Million
Q4 2022 Feb 14, 2023	BUY	$59.56 - $76.6 $5.38 Million - $6.92 Million	90,287 Added 33.98%	356,023 $22.3 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $1.55 Million - $2.09 Million	26,761 Added 11.2%	265,736 $18.7 Million
Q2 2022 Oct 27, 2022	BUY	$39.5 - $64.42 $6.74 Million - $11 Million	170,589 Added 249.45%	238,975 $13.5 Million
Q2 2022 Aug 15, 2022	BUY	$39.5 - $64.42 $6.74 Million - $11 Million	170,589 Added 249.45%	238,975 $13.5 Million
Q1 2022 Oct 27, 2022	SELL	$43.74 - $62.76 $7.46 Million - $10.7 Million	-170,589 Reduced 71.38%	68,386 $4.28 Million
Q1 2022 May 13, 2022	SELL	$43.74 - $62.76 $12.1 Million - $17.3 Million	-275,893 Reduced 80.14%	68,386 $4.28 Million
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $7.96 Million - $11.7 Million	159,123 Added 85.94%	344,279 $19.3 Million
Q3 2021 Nov 15, 2021	BUY	$59.21 - $78.66 $11 Million - $14.6 Million	185,156 New	185,156 $12.1 Million

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account